Hepatitis B immune globulin (Biotest Pharmaceuticals)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHepatitis B immune globulin (Biotest Pharmaceuticals)
Drug Alias Name +[6]ย
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1999/03/24
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNabi Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBiotest Pharmaceuticals Co
Active Indications
Inactive Indications